Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-05-27

Clinical Trial Update: Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion

View source ↗

Summary

This entry reports a completed retrospective data collection study assessing outcomes in patients with macular edema from retinal vein occlusion who received tw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Allergan | Conditions: Retinal Vein Occlusion, Macular Oedema | Status: COMPLETED | Results posted: 2013-05-27